School of Medicine
Showing 21-30 of 33 Results
-
Kristen K. Steenerson
Clinical Assistant Professor, Otolaryngology - Head & Neck Surgery Divisions
Bio Kristen Steenerson is a board-certified neurologist with fellowship training in otoneurology. After graduating cum laude from Claremont McKenna College where she was honored as an All-American lacrosse defensive player, she continued on to medical school at the University of Utah in Salt Lake City, Utah. After four years of excellent training and annual ski passes, she proceeded to the Mayo Clinic in Arizona for neurology residency. There, she discovered the beauty of the Sonoran Desert as well as an unmet need in balance disorders and vertigo, motivating her to pursue a fellowship in otoneurology at Barrow Neurological Institute. She joins Stanford with positions in both Otolaryngology--Head and Neck Surgery and Neurology with the goal of jointly addressing the junction of inner ear and brain disorders. Her specific interests include vestibular migraine, benign paroxysmal positional vertigo, Ménière's disease and international neurology.
-
Gary K. Steinberg, MD, PhD
Bernard and Ronni Lacroute-William Randolph Hearst Professor in Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology
Current Research and Scholarly Interests Our laboratory investigates the pathophysiology and treatment of cerebral ischemia, and methods to restore neurologic function after stroke. Treatment strategies include brain hypothermia, stem cell transplantation and optogenetic stimulation. Our clinical research develops innovative surgical, endovascular and radiosurgical approaches for treating difficult intracranial aneurysms, complex vascular malformations and occlusive disease, including Moyamoya disease, as well as stem cell transplant.
-
Lawrence Steinman, MD
George A. Zimmermann Professor and Professor of Pediatrics
Current Research and Scholarly Interests Our laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
-
Thomas Sudhof
Avram Goldstein Professor in the School of Medicine and Professor, by courtesy, of Neurology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Information transfer at synapses mediates information processing in brain, and is impaired in many brain diseases. Thomas Südhof is interested in how synapses are formed, how presynaptic terminals release neurotransmitters at synapses, and how synapses become dysfunctional in diseases such as autism or Alzheimer's disease. To address these questions, Südhof's laboratory employs approaches ranging from biophysical studies to the electrophysiological and behavioral analyses of mutant mice.